Clinical Trials Directory

Trials / Unknown

UnknownNCT01287312

Trichloroacetic Acid for Endoscopic Tracho-esophageal Fistula Repair

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
1 Month – 20 Years
Healthy volunteers
Not accepted

Summary

Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects. The investigators want to use also TCA 50% for endoscopic repair in children with recurrent TEF.

Detailed description

Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects. We want to use also TCA 50% for endoscopic repair in children with recurrent TEF.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopic repair of recurrent TEF by trichloroacetic acid aplications

Timeline

Start date
2011-01-01
Primary completion
2012-01-01
Completion
2013-01-01
First posted
2011-02-01
Last updated
2011-02-01

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01287312. Inclusion in this directory is not an endorsement.